162 related articles for article (PubMed ID: 35280287)
1. Case Report: Thymidine Kinase 2 (TK2) Deficiency: A Novel Mutation Associated With Childhood-Onset Mitochondrial Myopathy and Atypical Progression.
Manini A; Meneri M; Rodolico C; Corti S; Toscano A; Comi GP; Musumeci O; Ronchi D
Front Neurol; 2022; 13():857279. PubMed ID: 35280287
[TBL] [Abstract][Full Text] [Related]
2. Late-onset thymidine kinase 2 deficiency: a review of 18 cases.
Domínguez-González C; Hernández-Laín A; Rivas E; Hernández-Voth A; Sayas Catalán J; Fernández-Torrón R; Fuiza-Luces C; García García J; Morís G; Olivé M; Miralles F; Díaz-Manera J; Caballero C; Méndez-Ferrer B; Martí R; García Arumi E; Badosa MC; Esteban J; Jimenez-Mallebrera C; Encinar AB; Arenas J; Hirano M; Martin MÁ; Paradas C
Orphanet J Rare Dis; 2019 May; 14(1):100. PubMed ID: 31060578
[TBL] [Abstract][Full Text] [Related]
3. Retrospective natural history of thymidine kinase 2 deficiency.
Garone C; Taylor RW; Nascimento A; Poulton J; Fratter C; Domínguez-González C; Evans JC; Loos M; Isohanni P; Suomalainen A; Ram D; Hughes MI; McFarland R; Barca E; Lopez Gomez C; Jayawant S; Thomas ND; Manzur AY; Kleinsteuber K; Martin MA; Kerr T; Gorman GS; Sommerville EW; Chinnery PF; Hofer M; Karch C; Ralph J; Cámara Y; Madruga-Garrido M; Domínguez-Carral J; Ortez C; Emperador S; Montoya J; Chakrapani A; Kriger JF; Schoenaker R; Levin B; Thompson JLP; Long Y; Rahman S; Donati MA; DiMauro S; Hirano M
J Med Genet; 2018 Aug; 55(8):515-521. PubMed ID: 29602790
[TBL] [Abstract][Full Text] [Related]
4. Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum.
Béhin A; Jardel C; Claeys KG; Fagart J; Louha M; Romero NB; Laforêt P; Eymard B; Lombès A
Neurology; 2012 Feb; 78(9):644-8. PubMed ID: 22345218
[TBL] [Abstract][Full Text] [Related]
5. Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome.
Götz A; Isohanni P; Pihko H; Paetau A; Herva R; Saarenpää-Heikkilä O; Valanne L; Marjavaara S; Suomalainen A
Brain; 2008 Nov; 131(Pt 11):2841-50. PubMed ID: 18819985
[TBL] [Abstract][Full Text] [Related]
6. Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice.
Blázquez-Bermejo C; Molina-Granada D; Vila-Julià F; Jiménez-Heis D; Zhou X; Torres-Torronteras J; Karlsson A; Martí R; Cámara Y
EBioMedicine; 2019 Aug; 46():342-355. PubMed ID: 31351931
[TBL] [Abstract][Full Text] [Related]
7. Advances in Thymidine Kinase 2 Deficiency: Clinical Aspects, Translational Progress, and Emerging Therapies.
Berardo A; Domínguez-González C; Engelstad K; Hirano M
J Neuromuscul Dis; 2022; 9(2):225-235. PubMed ID: 35094997
[TBL] [Abstract][Full Text] [Related]
8. Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency.
Lopez-Gomez C; Levy RJ; Sanchez-Quintero MJ; Juanola-Falgarona M; Barca E; Garcia-Diaz B; Tadesse S; Garone C; Hirano M
Ann Neurol; 2017 May; 81(5):641-652. PubMed ID: 28318037
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.
Lopez-Gomez C; Hewan H; Sierra C; Akman HO; Sanchez-Quintero MJ; Juanola-Falgarona M; Tadesse S; Tanji K; Konofagou EE; Hirano M
EBioMedicine; 2019 Aug; 46():356-367. PubMed ID: 31383553
[TBL] [Abstract][Full Text] [Related]
10. Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes.
Wang L; Limongelli A; Vila MR; Carrara F; Zeviani M; Eriksson S
Mol Genet Metab; 2005 Jan; 84(1):75-82. PubMed ID: 15639197
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA depletion in single fibers in a patient with novel TK2 mutations.
Roos S; Lindgren U; Ehrstedt C; Moslemi AR; Oldfors A
Neuromuscul Disord; 2014 Aug; 24(8):713-20. PubMed ID: 24953930
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency.
Lopez-Gomez C; Sanchez-Quintero MJ; Lee EJ; Kleiner G; Tadesse S; Xie J; Akman HO; Gao G; Hirano M
Ann Neurol; 2021 Oct; 90(4):640-652. PubMed ID: 34338329
[TBL] [Abstract][Full Text] [Related]
13. Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene.
Chanprasert S; Wang J; Weng SW; Enns GM; Boué DR; Wong BL; Mendell JR; Perry DA; Sahenk Z; Craigen WJ; Alcala FJ; Pascual JM; Melancon S; Zhang VW; Scaglia F; Wong LJ
Mol Genet Metab; 2013; 110(1-2):153-61. PubMed ID: 23932787
[TBL] [Abstract][Full Text] [Related]
14. Thymidine kinase 2 enzyme kinetics elucidate the mechanism of thymidine-induced mitochondrial DNA depletion.
Sun R; Wang L
Biochemistry; 2014 Oct; 53(39):6142-50. PubMed ID: 25215937
[TBL] [Abstract][Full Text] [Related]
15. Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion.
Lesko N; Naess K; Wibom R; Solaroli N; Nennesmo I; von Döbeln U; Karlsson A; Larsson NG
Neuromuscul Disord; 2010 Mar; 20(3):198-203. PubMed ID: 20083405
[TBL] [Abstract][Full Text] [Related]
16. Myopathic mtDNA Depletion Syndrome Due to Mutation in TK2 Gene.
Martín-Hernández E; García-Silva MT; Quijada-Fraile P; Rodríguez-García ME; Rivera H; Hernández-Laín A; Coca-Robinot D; Fernández-Toral J; Arenas J; Martín MA; Martínez-Azorín F
Pediatr Dev Pathol; 2017; 20(5):416-420. PubMed ID: 28812460
[TBL] [Abstract][Full Text] [Related]
17. TK2 mutation presenting as indolent myopathy.
Paradas C; Gutiérrez Ríos P; Rivas E; Carbonell P; Hirano M; DiMauro S
Neurology; 2013 Jan; 80(5):504-6. PubMed ID: 23303857
[TBL] [Abstract][Full Text] [Related]
18. A defect in the thymidine kinase 2 gene causing isolated mitochondrial myopathy without mtDNA depletion.
Leshinsky-Silver E; Michelson M; Cohen S; Ginsberg M; Sadeh M; Barash V; Lerman-Sagie T; Lev D
Eur J Paediatr Neurol; 2008 Jul; 12(4):309-13. PubMed ID: 17951082
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications.
Priego EM; Karlsson A; Gago F; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
Curr Pharm Des; 2012; 18(20):2981-94. PubMed ID: 22571666
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
